| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 9.302 | 27.659 | 79.624 | 54.851 | 162.035 | 195.915 |
| Total Income - EUR | - | - | - | 0 | 33.566 | 28.896 | 82.277 | 56.215 | 163.863 | 197.379 |
| Total Expenses - EUR | - | - | - | 102 | 33.099 | 31.257 | 33.156 | 16.800 | 77.876 | 86.172 |
| Gross Profit/Loss - EUR | - | - | - | -102 | 467 | -2.362 | 49.121 | 39.415 | 85.987 | 111.207 |
| Net Profit/Loss - EUR | - | - | - | -102 | 374 | -2.671 | 46.733 | 38.406 | 84.610 | 106.145 |
| Employees | - | - | - | 0 | 2 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neurowellness S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 344 | 8.437 | 8.227 | 6.421 | 4.907 | 10.916 | 8.903 |
| Current Assets | - | - | - | 215 | 8.394 | 9.666 | 44.736 | 57.003 | 125.893 | 217.945 |
| Inventories | - | - | - | 0 | 0 | 41 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 417 | 1.005 | 1.405 | 37.021 | 1.287 | 71.425 |
| Cash | - | - | - | 215 | 7.977 | 8.620 | 43.331 | 19.982 | 124.605 | 146.521 |
| Shareholders Funds | - | - | - | 113 | 485 | -2.196 | 44.586 | 38.650 | 117.463 | 146.047 |
| Social Capital | - | - | - | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | 446 | 6.932 | 9.609 | 873 | 9.451 | 15.610 | 75.403 |
| Income in Advance | - | - | - | 0 | 9.587 | 10.817 | 5.959 | 13.903 | 3.824 | 5.573 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Neurowellness S.r.l.